{"id":"https://openalex.org/W2953593395","doi":"https://doi.org/10.1158/1538-7445.am2019-260","title":"Abstract 260: Identifying cancer drug sensitivity using live cell imaging dynamic BH3 profiling of solid tumor core biopsies","display_name":"Abstract 260: Identifying cancer drug sensitivity using live cell imaging dynamic BH3 profiling of solid tumor core biopsies","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2953593395","doi":"https://doi.org/10.1158/1538-7445.am2019-260","mag":"2953593395"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-260","doi":"https://doi.org/10.1158/1538-7445.am2019-260","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-260","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025865589","display_name":"Rebecca Mary German","orcid":"https://orcid.org/0009-0001-2545-9550","observed_orcids":["https://orcid.org/0009-0001-2545-9550"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca German","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024416854","display_name":"Elizaveta Lavrova","orcid":"https://orcid.org/0000-0002-3332-4592","observed_orcids":["https://orcid.org/0000-0002-3332-4592"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizaveta Lavrova","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061240965","display_name":"Timothy Hagan","orcid":"https://orcid.org/0000-0002-5990-6574","observed_orcids":["https://orcid.org/0000-0002-5990-6574"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Hagan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069291253","display_name":"Otari Chipashvili","orcid":"https://orcid.org/0000-0002-5454-2388","observed_orcids":["https://orcid.org/0000-0002-5454-2388"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Otari Chipashvili","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045074422","display_name":"Ewa Sici\u0144ska","orcid":"https://orcid.org/0000-0001-7187-319X","observed_orcids":["https://orcid.org/0000-0001-7187-319X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ewa Sicinska","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018655814","display_name":"James M. Cleary","orcid":"https://orcid.org/0000-0001-7213-3951","observed_orcids":["https://orcid.org/0000-0001-7213-3951"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Cleary","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077382664","display_name":"Kimmie Ng","orcid":"https://orcid.org/0000-0003-0631-1494","observed_orcids":["https://orcid.org/0000-0003-0631-1494"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimmie Ng","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022857112","display_name":"Anthony G. Letai","orcid":"https://orcid.org/0000-0002-1993-9013","observed_orcids":["https://orcid.org/0000-0002-1993-9013"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Letai","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018461011","display_name":"Patrick D. Bhola","orcid":"https://orcid.org/0000-0002-2438-4526","observed_orcids":["https://orcid.org/0000-0002-2438-4526"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Bhola","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"260","last_page":"260"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-drug-sensitivity","display_name":"cancer drug sensitivity","score":0.859000027179718},{"id":"https://openalex.org/keywords/live-cell-imaging","display_name":"live-cell imaging","score":0.7979999780654907},{"id":"https://openalex.org/keywords/mitochondrial-integrity","display_name":"mitochondrial integrity","score":0.843999981880188},{"id":"https://openalex.org/keywords/bh3-peptides","display_name":"BH3 peptides","score":0.8109999895095825},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6470000147819519},{"id":"https://openalex.org/keywords/predictive-diagnostics","display_name":"predictive diagnostics","score":0.5899999737739563},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8199999928474426},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.953000009059906},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/mmtv-pymt-mouse-model","display_name":"MMTV-PyMT mouse model","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.6808079481124878},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6102026104927063},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5961530208587646},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5834738612174988},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5255975723266602},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5002133846282959},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4689561724662781},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.44419369101524353},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.43565672636032104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3412874639034271},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32441452145576477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24123165011405945},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22432169318199158},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-260","doi":"https://doi.org/10.1158/1538-7445.am2019-260","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-260","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2954855348","https://openalex.org/W2432564198","https://openalex.org/W2484943995","https://openalex.org/W3034207086","https://openalex.org/W2023871119","https://openalex.org/W1571462588","https://openalex.org/W2496574993","https://openalex.org/W2313159643","https://openalex.org/W2165056381","https://openalex.org/W4310524834"],"abstract_inverted_index":{"Abstract":[0],"Given":[1],"the":[2,63,84,122,138,157,246],"rapid":[3],"development":[4],"of":[5,52,65,94,129,144,156,176,237,245],"new":[6],"small":[7,92],"molecule":[8],"cancer":[9,21,45,130,178,227],"therapeutics,":[10],"there":[11],"is":[12],"a":[13,29,34,78,194,199],"growing":[14],"need":[15],"for":[16,87,249],"predictive":[17],"diagnostics":[18],"to":[19,47,67,112,172,201],"match":[20],"patients":[22],"with":[23,33,91],"optimal":[24],"therapies.":[25],"We":[26,100,118,184],"previously":[27],"developed":[28],"precision":[30],"medicine":[31],"technology":[32],"functional":[35],"phenotypic":[36],"readout":[37],"called":[38],"dynamic":[39,234],"BH3":[40,113,235],"profiling":[41,236],"(DBP).":[42],"DBP":[43,66,85,154],"exposes":[44],"cells":[46,95,136],"drugs":[48],"and":[49,133,179,197],"measures":[50],"induction":[51],"apoptotic":[53],"cell":[54,105,131,232],"death":[55],"signaling":[56],"after":[57],"24":[58],"hours":[59],"ex":[60,152],"vivo.":[61],"Nonetheless,":[62],"application":[64],"core":[68,98,240],"biopsies":[69,241],"from":[70,137],"metastatic":[71],"tumors":[72],"or":[73],"other":[74],"limited":[75,127,135],"samples":[76,90],"remains":[77],"technical":[79],"challenge.":[80],"Here,":[81],"we":[82,148,167],"adapt":[83],"protocol":[86,124,171,189],"use":[88],"on":[89],"numbers":[93,128],"such":[96],"as":[97,193,198],"biopsies.":[99],"maximize":[101],"information":[102],"returned":[103],"per":[104],"by":[106],"imaging":[107,233],"mitochondrial":[108],"integrity":[109],"in":[110,126,134,163],"response":[111],"peptide":[114],"exposure":[115],"over":[116],"time.":[117],"first":[119],"show":[120,149],"that":[121,150,186],"adapted":[123,188],"works":[125],"lines,":[132],"MMTV-PyMT":[139,158],"genetically":[140],"engineered":[141],"mouse":[142,159],"model":[143],"breast":[145],"cancer.":[146],"Specifically,":[147],"our":[151,169,187],"vivo":[153,164],"predictions":[155],"tumor":[160,239],"matches":[161],"known":[162],"response.":[165],"Finally,":[166],"apply":[168],"modified":[170],"patient":[173,181],"derived":[174],"xenografts":[175],"colon":[177,182],"primary":[180],"tumors.":[183],"expect":[185],"will":[190],"find":[191],"utility":[192],"clinical":[195],"biomarker,":[196],"method":[200],"optimize":[202],"pre-clinical":[203],"drug":[204,228],"testing.":[205],"Citation":[206],"Format:":[207],"Rebecca":[208],"German,":[209],"Elizaveta":[210],"Lavrova,":[211],"Timothy":[212],"Hagan,":[213],"Otari":[214],"Chipashvili,":[215],"Ewa":[216],"Sicinska,":[217],"James":[218],"Cleary,":[219],"Kimmie":[220],"Ng,":[221],"Anthony":[222],"Letai,":[223],"Patrick":[224],"Bhola.":[225],"Identifying":[226],"sensitivity":[229],"using":[230],"live":[231],"solid":[238],"[abstract].":[242],"In:":[243],"Proceedings":[244],"American":[247],"Association":[248],"Cancer":[250,264],"Research":[251],"Annual":[252],"Meeting":[253],"2019;":[254],"2019":[255],"Mar":[256],"29-Apr":[257],"3;":[258],"Atlanta,":[259],"GA.":[260],"Philadelphia":[261],"(PA):":[262],"AACR;":[263],"Res":[265],"2019;79(13":[266],"Suppl):Abstract":[267],"nr":[268],"260.":[269]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-07-12T00:00:00"}